Dick's Sporting Goods, Inc. (DKS) Reports In-Line Q4 EPS; Issues Mixed Q1, FY14 Outlook
Get Alerts DKS Hot Sheet
Price: $202.26 -0.2%
Financial Fact:
Pre-opening expenses: 19.3M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Pre-opening expenses: 19.3M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Dick's Sporting Goods, Inc. (NYSE: DKS) reported Q4 EPS of $1.11, in-line with the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.94 billion.
Consolidated same store sales for the fourth quarter increased 7.3%, adjusted for the shifted calendar.
Sees FY2014 EPS of $3.03-$3.08, versus the consensus of $2.70. Consolidated same store sales are currently expected to increase approximately 3 to 4%, compared to a 1.9% increase in fiscal 2013.
Sees Q1 2014 EPS of $0.51-$0.53, versus the consensus of $0.54. Consolidated same store sales are currently expected to increase 3 to 4% in the first quarter of 2014, compared to a 3.8% decrease in the first quarter of 2013, adjusted for the shifted retail calendar due to the 53rd week in 2012.
For earnings history and earnings-related data on Dick's Sporting Goods, Inc. (DKS) click here.
Consolidated same store sales for the fourth quarter increased 7.3%, adjusted for the shifted calendar.
Sees FY2014 EPS of $3.03-$3.08, versus the consensus of $2.70. Consolidated same store sales are currently expected to increase approximately 3 to 4%, compared to a 1.9% increase in fiscal 2013.
Sees Q1 2014 EPS of $0.51-$0.53, versus the consensus of $0.54. Consolidated same store sales are currently expected to increase 3 to 4% in the first quarter of 2014, compared to a 3.8% decrease in the first quarter of 2013, adjusted for the shifted retail calendar due to the 53rd week in 2012.
For earnings history and earnings-related data on Dick's Sporting Goods, Inc. (DKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share